Report cover image

Global Blood Preparation Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 196 Pages
SKU # APRC20556571

Description

Summary

According to APO Research, the global Blood Preparation market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Blood Preparation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Blood Preparation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Blood Preparation market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Blood Preparation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Blood Preparation market include Pfizer, GlaxoSmithKline, Baxter Healthcare Corp, AstraZeneca, Sanofi Aventis, Leo Pharma, Celgene Corporation and Bristol-Myers Squibb Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Blood Preparation, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Blood Preparation, also provides the sales of main regions and countries. Of the upcoming market potential for Blood Preparation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Preparation sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Blood Preparation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Blood Preparation sales, projected growth trends, production technology, application and end-user industry.

Blood Preparation Segment by Company

Pfizer
GlaxoSmithKline
Baxter Healthcare Corp
AstraZeneca
Sanofi Aventis
Leo Pharma
Celgene Corporation
Bristol-Myers Squibb Company
Blood Preparation Segment by Type

Blood Components
Whole Blood
Blood Derivatives
Blood Preparation Segment by Application

Thrombocytosis
Angina Blood Vessel Complications
Renal Impairment
Pulmonary Embolism
Others
Blood Preparation Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Blood Preparation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Blood Preparation market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blood Preparation significant trends, drivers, influence factors in global and regions.
6. To analyze Blood Preparation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Preparation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Preparation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Preparation industry.
Chapter 3: Detailed analysis of Blood Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Blood Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Blood Preparation in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Blood Preparation Sales Value (2020-2031)
1.2.2 Global Blood Preparation Sales Volume (2020-2031)
1.2.3 Global Blood Preparation Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Blood Preparation Market Dynamics
2.1 Blood Preparation Industry Trends
2.2 Blood Preparation Industry Drivers
2.3 Blood Preparation Industry Opportunities and Challenges
2.4 Blood Preparation Industry Restraints
3 Blood Preparation Market by Company
3.1 Global Blood Preparation Company Revenue Ranking in 2024
3.2 Global Blood Preparation Revenue by Company (2020-2025)
3.3 Global Blood Preparation Sales Volume by Company (2020-2025)
3.4 Global Blood Preparation Average Price by Company (2020-2025)
3.5 Global Blood Preparation Company Ranking (2023-2025)
3.6 Global Blood Preparation Company Manufacturing Base and Headquarters
3.7 Global Blood Preparation Company Product Type and Application
3.8 Global Blood Preparation Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Blood Preparation Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Blood Preparation Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Blood Preparation Market by Type
4.1 Blood Preparation Type Introduction
4.1.1 Blood Components
4.1.2 Whole Blood
4.1.3 Blood Derivatives
4.2 Global Blood Preparation Sales Volume by Type
4.2.1 Global Blood Preparation Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Blood Preparation Sales Volume by Type (2020-2031)
4.2.3 Global Blood Preparation Sales Volume Share by Type (2020-2031)
4.3 Global Blood Preparation Sales Value by Type
4.3.1 Global Blood Preparation Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Blood Preparation Sales Value by Type (2020-2031)
4.3.3 Global Blood Preparation Sales Value Share by Type (2020-2031)
5 Blood Preparation Market by Application
5.1 Blood Preparation Application Introduction
5.1.1 Thrombocytosis
5.1.2 Angina Blood Vessel Complications
5.1.3 Renal Impairment
5.1.4 Pulmonary Embolism
5.1.5 Others
5.2 Global Blood Preparation Sales Volume by Application
5.2.1 Global Blood Preparation Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Blood Preparation Sales Volume by Application (2020-2031)
5.2.3 Global Blood Preparation Sales Volume Share by Application (2020-2031)
5.3 Global Blood Preparation Sales Value by Application
5.3.1 Global Blood Preparation Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Blood Preparation Sales Value by Application (2020-2031)
5.3.3 Global Blood Preparation Sales Value Share by Application (2020-2031)
6 Blood Preparation Regional Sales and Value Analysis
6.1 Global Blood Preparation Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Blood Preparation Sales by Region (2020-2031)
6.2.1 Global Blood Preparation Sales by Region: 2020-2025
6.2.2 Global Blood Preparation Sales by Region (2026-2031)
6.3 Global Blood Preparation Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Blood Preparation Sales Value by Region (2020-2031)
6.4.1 Global Blood Preparation Sales Value by Region: 2020-2025
6.4.2 Global Blood Preparation Sales Value by Region (2026-2031)
6.5 Global Blood Preparation Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Blood Preparation Sales Value (2020-2031)
6.6.2 North America Blood Preparation Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Blood Preparation Sales Value (2020-2031)
6.7.2 Europe Blood Preparation Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Blood Preparation Sales Value (2020-2031)
6.8.2 Asia-Pacific Blood Preparation Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Blood Preparation Sales Value (2020-2031)
6.9.2 South America Blood Preparation Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Blood Preparation Sales Value (2020-2031)
6.10.2 Middle East & Africa Blood Preparation Sales Value Share by Country, 2024 VS 2031
7 Blood Preparation Country-level Sales and Value Analysis
7.1 Global Blood Preparation Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Blood Preparation Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Blood Preparation Sales by Country (2020-2031)
7.3.1 Global Blood Preparation Sales by Country (2020-2025)
7.3.2 Global Blood Preparation Sales by Country (2026-2031)
7.4 Global Blood Preparation Sales Value by Country (2020-2031)
7.4.1 Global Blood Preparation Sales Value by Country (2020-2025)
7.4.2 Global Blood Preparation Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Blood Preparation Sales Value Growth Rate (2020-2031)
7.5.2 USA Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Blood Preparation Sales Value Growth Rate (2020-2031)
7.6.2 Canada Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Blood Preparation Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Blood Preparation Sales Value Growth Rate (2020-2031)
7.8.2 Germany Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Blood Preparation Sales Value Growth Rate (2020-2031)
7.9.2 France Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.9.3 France Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Blood Preparation Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Blood Preparation Sales Value Growth Rate (2020-2031)
7.11.2 Italy Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Blood Preparation Sales Value Growth Rate (2020-2031)
7.12.2 Spain Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Blood Preparation Sales Value Growth Rate (2020-2031)
7.13.2 Russia Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Blood Preparation Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Blood Preparation Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Blood Preparation Sales Value Growth Rate (2020-2031)
7.16.2 China Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.16.3 China Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Blood Preparation Sales Value Growth Rate (2020-2031)
7.17.2 Japan Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Blood Preparation Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Blood Preparation Sales Value Growth Rate (2020-2031)
7.19.2 India Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.19.3 India Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Blood Preparation Sales Value Growth Rate (2020-2031)
7.20.2 Australia Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Blood Preparation Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Blood Preparation Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Blood Preparation Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Blood Preparation Sales Value Growth Rate (2020-2031)
7.24.2 Chile Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Blood Preparation Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Blood Preparation Sales Value Growth Rate (2020-2031)
7.26.2 Peru Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Blood Preparation Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Blood Preparation Sales Value Growth Rate (2020-2031)
7.28.2 Israel Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Blood Preparation Sales Value Growth Rate (2020-2031)
7.29.2 UAE Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Blood Preparation Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Blood Preparation Sales Value Growth Rate (2020-2031)
7.31.2 Iran Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Blood Preparation Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Blood Preparation Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Blood Preparation Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Blood Preparation Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Pfizer
8.1.1 Pfizer Comapny Information
8.1.2 Pfizer Business Overview
8.1.3 Pfizer Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.1.4 Pfizer Blood Preparation Product Portfolio
8.1.5 Pfizer Recent Developments
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Comapny Information
8.2.2 GlaxoSmithKline Business Overview
8.2.3 GlaxoSmithKline Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.2.4 GlaxoSmithKline Blood Preparation Product Portfolio
8.2.5 GlaxoSmithKline Recent Developments
8.3 Baxter Healthcare Corp
8.3.1 Baxter Healthcare Corp Comapny Information
8.3.2 Baxter Healthcare Corp Business Overview
8.3.3 Baxter Healthcare Corp Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.3.4 Baxter Healthcare Corp Blood Preparation Product Portfolio
8.3.5 Baxter Healthcare Corp Recent Developments
8.4 AstraZeneca
8.4.1 AstraZeneca Comapny Information
8.4.2 AstraZeneca Business Overview
8.4.3 AstraZeneca Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.4.4 AstraZeneca Blood Preparation Product Portfolio
8.4.5 AstraZeneca Recent Developments
8.5 Sanofi Aventis
8.5.1 Sanofi Aventis Comapny Information
8.5.2 Sanofi Aventis Business Overview
8.5.3 Sanofi Aventis Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.5.4 Sanofi Aventis Blood Preparation Product Portfolio
8.5.5 Sanofi Aventis Recent Developments
8.6 Leo Pharma
8.6.1 Leo Pharma Comapny Information
8.6.2 Leo Pharma Business Overview
8.6.3 Leo Pharma Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.6.4 Leo Pharma Blood Preparation Product Portfolio
8.6.5 Leo Pharma Recent Developments
8.7 Celgene Corporation
8.7.1 Celgene Corporation Comapny Information
8.7.2 Celgene Corporation Business Overview
8.7.3 Celgene Corporation Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.7.4 Celgene Corporation Blood Preparation Product Portfolio
8.7.5 Celgene Corporation Recent Developments
8.8 Bristol-Myers Squibb Company
8.8.1 Bristol-Myers Squibb Company Comapny Information
8.8.2 Bristol-Myers Squibb Company Business Overview
8.8.3 Bristol-Myers Squibb Company Blood Preparation Sales, Value and Gross Margin (2020-2025)
8.8.4 Bristol-Myers Squibb Company Blood Preparation Product Portfolio
8.8.5 Bristol-Myers Squibb Company Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Blood Preparation Value Chain Analysis
9.1.1 Blood Preparation Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Blood Preparation Sales Mode & Process
9.2 Blood Preparation Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Blood Preparation Distributors
9.2.3 Blood Preparation Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.